Claritev EBITDA Margin 2019-2025 | CTEV

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Claritev (CTEV) over the last 10 years. The current EBITDA margin for Claritev as of March 31, 2025 is .
Claritev EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.93B $-0.44B -47.84%
2024-12-31 $0.93B $-0.94B -101.29%
2024-09-30 $0.94B $-0.86B -91.40%
2024-06-30 $0.96B $-0.49B -50.89%
2024-03-31 $0.96B $0.07B 6.98%
2023-12-31 $0.96B $0.60B 62.27%
2023-09-30 $0.96B $-0.06B -6.26%
2023-06-30 $0.97B $-0.07B -6.94%
2023-03-31 $1.02B $0.00B -0.29%
2022-12-31 $1.08B $0.06B 5.84%
2022-09-30 $1.14B $0.80B 69.98%
2022-06-30 $1.17B $0.85B 72.74%
2022-03-31 $1.16B $0.85B 72.93%
2021-12-31 $1.12B $0.81B 72.61%
2021-09-30 $1.07B $0.65B 60.24%
2021-06-30 $1.01B $0.34B 33.76%
2021-03-31 $0.94B $0.27B 28.48%
2020-12-31 $0.94B $0.27B 28.89%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.686B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.594B 60.55
Hims & Hers Health (HIMS) United States $12.830B 133.30
Doximity (DOCS) United States $11.392B 52.74
Tempus AI (TEM) United States $10.965B 0.00
IRhythm Technologies (IRTC) United States $4.223B 0.00
Inspire Medical Systems (INSP) United States $3.794B 59.28
Hinge Health (HNGE) United States $3.587B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.691B 0.00
Schrodinger (SDGR) United States $1.650B 0.00
Phreesia (PHR) United States $1.610B 0.00
Clover Health Investments (CLOV) United States $1.565B 0.00
Azenta (AZTA) United States $1.555B 72.25
Enovis (ENOV) United States $1.551B 8.65
Omnicell (OMCL) United States $1.318B 23.25
Evolent Health (EVH) United States $1.098B 93.50
Fulgent Genetics (FLGT) United States $0.560B 0.00
Standard BioTools (LAB) United States $0.558B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Talkspace (TALK) United States $0.422B 126.00
TruBridge (TBRG) United States $0.349B 775.00
Outset Medical (OM) United States $0.312B 0.00
Health Catalyst (HCAT) United States $0.268B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.198B 0.00
Zepp Health (ZEPP) Netherlands $0.165B 0.00
KORU Medical Systems (KRMD) United States $0.162B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.106B 0.00
CareCloud (CCLD) United States $0.100B 3.82
Insight Molecular Diagnostics (IMDX) United States $0.085B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.022B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00